Archive

3 posts

Filters: tag: hhs-study Clear

The “FDA Proof” MBFC Cited Against RF Safe Was Removed

Independent Voices RF Safe Jan 25, 2026

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA consumer pages also redirect and that the strongest reassurance language is now mainly accessible via archives. It further cites Reuters reporting that FDA removed outdated webpages about cellphone safety alongside HHS launching a new study, and contends MBFC should update its rationale and links.

FDA Removes “Safety Conclusion” Cellphone Radiation Pages as HHS Announces a New Study—Why the “NTP Was Too High Dose” Talking Point Fails

Independent Voices RF Safe Jan 17, 2026

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

A Monumental Shift: FDA’s Cellphone Radiation Page Overhaul – From Unsubstantiated Safety Claims to Embracing the 1968 Mandate

Policy RF Safe Jan 16, 2026

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

Page 1 / 1